<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04123028</url>
  </required_header>
  <id_info>
    <org_study_id>60-319-14-3</org_study_id>
    <nct_id>NCT04123028</nct_id>
  </id_info>
  <brief_title>The Association Between Blood Eosinophilsp in Thai COPD Patients: A Prospective Study</brief_title>
  <official_title>The Association Between Blood Eosinophils and Clinical Outcomes of Chronic Obstructive Pulmonary Disease Patients: A Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prince of Songkla University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Prince of Songkla University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The association of blood eosinophil as a biomarker for eosinophilic Thai COPD patients, such
      as COPD exacerbation, hospital admission, lung functions and mortlity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prospective one year study in Thai COPD patients for the clinical outcomes of COPD
      compare between eosinophilic and non-eosinophilic which determine by blood eosinophil counts
      equal or more than 300 cells/microliters. The primary outcomes was COPD exacerbation, the
      secondary outcomes were lung function, dyspnea and quality of life.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Acute worsening of respiratory symptoms</measure>
    <time_frame>1 year</time_frame>
    <description>acute severe worsening of respiratory symptoms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physiological outcomes</measure>
    <time_frame>1 year</time_frame>
    <description>Forced expiratory volume in one second</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>health related quality of life</measure>
    <time_frame>1 year</time_frame>
    <description>Chronic Obstructive Pulmonary Disease Assessment Test (CAT) scores which the minimum 0 and maximum 40 values, and whether higher scores mean a worse outcome.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">145</enrollment>
  <condition>Copd</condition>
  <arm_group>
    <arm_group_label>eosinophilic COPD patient</arm_group_label>
    <description>COPD patient with blood eosinophil equal or &gt; 300 cells/µL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-eosinophilic COPD patient</arm_group_label>
    <description>COPD patient with blood eosinophil &lt; 300 cells/µL</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>observatory</intervention_name>
    <description>observation for 1 year period</description>
    <arm_group_label>eosinophilic COPD patient</arm_group_label>
    <arm_group_label>non-eosinophilic COPD patient</arm_group_label>
    <other_name>clinical outcomes</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Thai COPD patients in out-patient department
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of COPD by GOLD criteria

        Exclusion Criteria:

          1. high blood eosinophil from known causes such as systemic corticosteroid use,
             malignancy, parasitic infection

          2. Patients who had previous acute exacerbation within 30-day before study entry

          3. Patients who had previous systemic corticosteroids used within 30-day before study
             entry
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kanung Saejiam, MS</last_name>
    <role>Study Director</role>
    <affiliation>Prince of Songkla University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine, Prince of Songkla university</name>
      <address>
        <city>Songkhla</city>
        <zip>90110</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Bafadhel M, Pavord ID, Russell REK. Eosinophils in COPD: just another biomarker? Lancet Respir Med. 2017 Sep;5(9):747-759. doi: 10.1016/S2213-2600(17)30217-5. Epub 2017 Jun 7. Review. Erratum in: Lancet Respir Med. 2017 Aug;5(8):e28.</citation>
    <PMID>28601554</PMID>
  </reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 8, 2019</study_first_submitted>
  <study_first_submitted_qc>October 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 10, 2019</study_first_posted>
  <last_update_submitted>October 9, 2019</last_update_submitted>
  <last_update_submitted_qc>October 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Prince of Songkla University</investigator_affiliation>
    <investigator_full_name>Siwasak Juthong</investigator_full_name>
    <investigator_title>Faculty of Medicine</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

